All Stories

  1. Senolytic therapy reduces inflammation in epithelial cells from COPD patients and in smoke-exposure mice
  2. Dasatinib attenuates airway inflammation of asthma exacerbation in mice induced by house dust mites and dsRNA
  3. Anti-inflammatory Effects of a Src Inhibitor on the Murine Model of Asthma Exacerbation Induced by Ovalbumin and Lipopolysaccharide
  4. Relationship between anti-fungal effects and lung exposure of PC945, a novel inhaled antifungal agent, in Aspergillus fumigatus infected mice
  5. Antifungal Effects of PC945, a Novel Inhaled Triazole, on Candida albicans Pulmonary Infection in Immunocompromised Mice
  6. Inhibitory Effects of Dabigatran on Airway Inflammation Induced by Lipopolysaccharide in Mice
  7. Anti-fungal activity of a novel triazole, PC1244, against emerging azole-resistant Aspergillus fumigatus and other species of Aspergillus
  8. Antifungal synergy of a topical triazole, PC945, with a systemic triazole against respiratory Aspergillus fumigatus infection
  9. TNF-α Decreased Corticosteroid Responsiveness in Mice Models of Airway Inflammation Induced by Double Strand RNA and/or Tobacco Smoke Exposure
  10. The Involvement of Src in Airway Inflammation Induced by Repeated Exposure to Lipopolysaccharide in Mice
  11. In VitroandIn VivoEfficacy of a Novel and Long-Acting Fungicidal Azole, PC1244, onAspergillus fumigatusInfection
  12. N 1 -Nonyl-1,4-diaminobutane ameliorates brain infarction size in photochemically induced thrombosis model mice
  13. RV568, a narrow-spectrum kinase inhibitor with p38 MAPK-α and -γ selectivity, suppresses COPD inflammation
  14. Effects of intranasally dosed posaconazole on fungal load and biomarkers in Aspergillus fumigatus infected immunocompromised mice
  15. In Vivo Biomarker Analysis of the Effects of Intranasally Dosed PC945, a Novel Antifungal Triazole, on Aspergillus fumigatus Infection in Immunocompromised Mice
  16. In Vitro and In Vivo Antifungal Profile of a Novel and Long-Acting Inhaled Azole, PC945, on Aspergillus fumigatus Infection
  17. Effects of phosphoinositide-3-kinase inhibitors on steroid-insensitive airway inflammation in poly(I:C) and allergen challenged mice
  18. The combination of TNF-α neutralization and dexamethasone treatment restored the corticosteroid responsiveness in tobacco smoking mice
  19. LPS causes corticosteroid insensitive airway inflammation via activation of PI3Kδ.
  20. Discovery of Narrow Spectrum Kinase Inhibitors: New Therapeutic Agents for the Treatment of COPD and Steroid-Resistant Asthma
  21. In Vivo Biomarker Analysis of Intranasally Dosed PC945, a Novel Antifungal Agent, in Aspergillus Fumigatus Infection in Immunocompromised Mice
  22. Corticosteroid sensitivity in intractable respiratory disease

  23. Correction: Activation of Transcription Factor Nrf2 Signalling by the Sphingosine Kinase Inhibitor SKI-II Is Mediated by the Formation of Keap1 Dimers
  24. Activation of Transcription Factor Nrf2 Signalling by the Sphingosine Kinase Inhibitor SKI-II Is Mediated by the Formation of Keap1 Dimers
  25. Toll-like Receptor 3 Stimulation Causes Corticosteroid-Refractory Airway Neutrophilia and Hyperresponsiveness in Mice
  26. Antagonism of NMDA receptors by butanesulfonyl-homospermine guanidine and neuroprotective effects in in vitro and in vivo
  27. Effects Of RV1088, A Narrow Spectrum Kinase Inhibitor, On Airway Inflammation And Hyperresponsiveness In Tobacco-Smoke Exposed Mice
  28. Superior Effects Of Combination Of PI3Kgamma And Delta; Inhibitors To Each Inhibitor Alone On Airway Inflammation In Tobacco-Smoke Exposed Mice
  29. Effects Of RV568, A Narrow Spectrum Kinase Inhibitor, On Airway Inflammation And Hyperresponsiveness In Tobacco-Smoke Exposed Mice
  30. Targeting Phosphoinositide-3-Kinase-δ with Theophylline Reverses Corticosteroid Insensitivity in Chronic Obstructive Pulmonary Disease
  31. Involvement Of P38MAPK Gamma On Corticosteroid Refractory Airway Inflammation Induced By Tobacco Smoke In Mice
  32. Synthesis of Water-Soluble Polyamine Derivatives Effective as N-Methyl-D-aspartate Receptor Antagonists
  33. Thrombin-stimulated proliferation is mediated by endothelin-1 in cultured rat gingival fibroblasts
  34. Neuroprotection by Tosyl-Polyamine Derivatives through the Inhibition of Ionotropic Glutamate Receptors
  35. Synthesis of a Novel Water-Soluble Cleft-Type Cyclophane as an N-Methyl-D-aspartate Receptor Antagonist
  36. Synthesis of Two Novel Water-soluble Cleft-Type Cyclophanes Effective as N-Methyl-D-aspartate Receptor Antagonist
  37. Differential effects of linear and cyclic polyamines on NMDA receptor activities
  38. Cleft-type cyclophanes confer neuroprotection against excitatory neurotoxicity in vitro and in vivo through inhibition of NMDA receptors
  39. Cyclophane and acyclic cyclophane: Novel channel blockers of N-methyl-d-aspartate receptor
  40. Effects of Dexamethasone and Aminophylline on Survival of Jurkat and HL-60 Cells
  41. Inhibition of angiotensin II- and endothelin-1-stimulated proliferation by selective MEK inhibitor in cultured rabbit gingival fibroblasts+
  42. Design and Synthesis of a Novel Water-Soluble NMDA Receptor Antagonist with a 1,4,7,10-Tetraazacyclododecane Group
  43. Monoamines directly inhibit N-methyl-d-aspartate receptors expressed in Xenopus oocytes in a voltage-dependent manner
  44. Proliferative response to phenytoin and nifedipine in gingival fibroblasts cultured from humans with gingival fibromatosis
  45. Pharmacological properties of angiotensin II receptors in cultured rabbit gingival fibroblasts
  46. Proliferative effects of angiotensin II and endothelin-1 on guinea pig gingival fibroblast cells in culture
  47. Effects of endothelin-1 and nitric oxide on proliferation of cultured guinea pig bronchial smooth muscle cells
  48. Involvement of angiotensin II and endothelin-1 in the development of submandibular gland hypertrophy in response to isoproterenol in rats
  49. Evidence for the AT1 Subtype of the Angiotensin II Receptor in the Rat Submandibular Gland.
  50. Activation of Protein Kinase C Induces Internalization of the GABAC Receptors Expressed in Xenopus Oocytes
  51. Antigen-induced elevation of immunoreactive endothelin-1 (ET-1) levels in ovalbumin-sensitized guinea pig airway tissue
  52. Consensus phosphorylation sites of human GABAC/GABAρ receptors are not critical for inhibition by protein kinase C activation
  53. β-Funaltrexamine Discriminates between Two Subtypes of μ2-Opioid Receptors in Electrically Stimulated Longitudinal Muscle of Guinea Pig Ileum
  54. Synergistic actions of pentobarbital and dihydropyridine Ca2+antagonists on guinea pig isolated thoracic aorta
  55. GABA θ1 receptor: inhibition by protein kinase C activators
  56. Effects of organic and inorganic Ca2+-antagonists on acetylcholine-induced contraction in molluscan (Mytilus edulis) smooth muscle
  57. Immunochemical and immunohistochemical determination of ubiquitin in molluscan (Mytilus edulis) smooth muscle
  58. Inhibitory action of McN-A-343 on acetylcholine-induced contraction in molluscan smooth muscle
  59. Possible site of action of 2-methylserotonin in inducing relaxation of acetylcholine-induced contraction in the molluscan (Mytilus edulis) smooth muscle
  60. Effect of ageing on response to nicotine in rabbit bronchial preparation
  61. Organic Ca2+-antagonist-resistant response to FMRF-NH2 on the molluscan smooth muscle
  62. Effects of chronic nicotine treatment on nicotinic receptors in the rabbit urinary bladder
  63. Effect of ageing on nicotine-induced contraction of guinea-pig bronchial preparation
  64. Substance P-containing nerves mediate nicotine-induced contractions of rabbit bronchial smooth muscle
  65. Pharmacological action of nicotine in the isolated urinary bladder from rabbit: Special reference to the chronic nicotine treatment
  66. Characterization of nicotine-induced contraction in the canine bronchus
  67. Noncholinergic contractile response to nicotine in the guinea pig isolated tracheal smooth muscle
  68. (±)-1-[[2-(3,4-Dimethoxphenyl) ethyl]amino]-3-(3-methylphenoxy)-2-propanol hydrochloride (bevantolol, NC-1400) as a β1-selective adrenoceptor blocker with α1-adrenoceptor blocking activity
  69. Actions of 4-(2-hydroxy-3-[(1-methyl-3-phenylpropyl)amino]propoxy)benzeneacetamide (KF4317) and labetalol on α- and β-adrenoceptors
  70. Mechanism of action of nicotine on crab-eating monkey isolated bronchial smooth muscle
  71. Possible involvement of substance P immunoreactive nerves in the mediation of nicotine-induced contractile responses in isolated guinea pig bronchus
  72. Tetrodotoxin-resistant response to nicotine in rabbit bronchial preparation
  73. Nicotinic stimulant, DMPP(1,1-dimethyl-4-phenylpiperazinium iodide) on the isolated bronchial smooth muscle preparation of guinea-pig
  74. Action of nicotine on guinea-pig isolated bronchial smooth muscle preparation
  75. A possible site of action of nicotine in the bronchial smooth muscle preparation of guinea-pig
  76. A receptor reserve of the alpha-inhibitory receptor for alpha-adrenoceptor stimulants in the taenia caecum of guinea pig.